Suchergebnisse - "Vaccines, Combined"

PubPharm (3.226)

1

Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants ≥ 2 and < 43 months of Age : A phase III, multicenter, active controlled, assessor-blinded, randomized, parallel-group study

enthalten in: Vaccine | 2024

von Nakano, T. | Hasegawa, M. | Endo, M. | +2

2

Bivalent conjugate vaccines for typhoid and paratyphoid fever

enthalten in: Lancet (London, England) | 2024

von Raqib, R.

3

The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults : a phase 1, randomised, active-controlled, double-blind trial

enthalten in: Lancet (London, England) | 2024

von Kulkarni, P. | Potey, A. | Bharati, S. | +24

4

Production of a new tetravalent vaccine targeting fimbriae and enterotoxin of enterotoxigenic Escherichia coli

enthalten in: Canadian journal of veterinary research = Revue canadienne de recherche veterinaire | 2024

von Xu, C. | She, Y. | Fu, F. | +1

5

Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years : Recommendations of the Advisory Committee on Immunization Practices - United States, 2023

enthalten in: MMWR. Morbidity and mortality weekly report | 2024

von Collins, J. | Crowe, S. | Ortega-Sanchez, I. | +6

6

Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023

enthalten in: Vaccine | 2024

von Plumb, I. | Briggs Hagen, M. | Wiegand, R. | +39

7

The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines

enthalten in: The New England journal of medicine | 2024

von Monto, A. | Zambon, M. | Weir, J.

8

Immunogenicity evaluation of a bivalent vaccine based on a recombinant rabies virus expressing gB protein of FHV-1 in mice and cats

enthalten in: Veterinary journal (London, England : 1997) | 2024

von Jiao, C. | Liu, D. | Jin, H. | +4

9

Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes : a double-blind randomised placebo-controlled Phase I trial

enthalten in: Diabetologia | 2024

von Hyöty, H. | Kääriäinen, S. | Laiho, J. | +11

10

Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza

enthalten in: Virology journal | 2024

von Stepanova, E. | Isakova-Sivak, I. | Mezhenskaya, D. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[323]